{
    "Trade/Device Name(s)": [
        "Preview Digital Pregnancy Test",
        "Preview\u00ae Digital Pregnancy Test"
    ],
    "Submitter Information": "Guangzhou Wondfo Biotech Co., Ltd.",
    "510(k) Number": "K173229",
    "Predicate Device Reference 510(k) Number(s)": [
        "K043443"
    ],
    "Regulatory Class": "Class II",
    "Product Code(s)": [
        "LCX"
    ],
    "Summary Letter Date": "February 8, 2018",
    "Summary Letter Received Date": "February 12, 2018",
    "Submission Date": "February 6, 2018",
    "Regulation Number(s)": [
        "21 CFR 862.1155"
    ],
    "Regulation Name(s)": [
        "Human chorionic gonadotropin (HCG) test system"
    ],
    "Analyte Class(es)": [
        "endocrine"
    ],
    "Analyte(s)": [
        "Human chorionic gonadotropin (hCG)"
    ],
    "Specimen Type(s)": [
        "Urine"
    ],
    "Specimen Container(s)": [],
    "Instrument(s)/Platform(s)": [
        "Preview\u00ae Digital Pregnancy Test device"
    ],
    "Method(s)/Technology(ies)": [
        "Immunochromatographic assay",
        "Lateral flow sandwich immunoassay"
    ],
    "Methodologies": [
        "Qualitative detection"
    ],
    "Submission Type(s)": [
        "Test",
        "Device"
    ],
    "Document Summary": "FDA 510(k) summary for Preview Digital Pregnancy Test for qualitative detection of hCG in urine using immunochromatographic assay",
    "Indications for Use Summary": "Intended for the qualitative detection of human chorionic gonadotropin (hCG) in urine, as an aid in early detection of pregnancy",
    "fda_folder": "Clinical Chemistry"
}